<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02902094</url>
  </required_header>
  <id_info>
    <org_study_id>RRK5479</org_study_id>
    <nct_id>NCT02902094</nct_id>
  </id_info>
  <brief_title>Drug Eluting Balloon Venoplasty in AV Fistula Stenosis</brief_title>
  <acronym>DeVA</acronym>
  <official_title>Improving Outcomes in Fistula Intervention: A Prospective, Patient Blinded, Phase 3, Randomised Controlled Trial of Drug Eluting Balloons in the Angioplasty of Native Haemodialysis Access Arteriovenous Fistula Outflow Stenosis (DeVA)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Birmingham</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital Birmingham</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      DeVA is a single blinded, prospective, multicentre RCT designed to determine the safety and
      effectiveness of a drug eluting angioplasty balloon compared with a standard angioplasty
      balloon in patients with symptomatic native AV fistula stenosis.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Anticipated">January 2019</completion_date>
  <primary_completion_date type="Anticipated">January 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Patency</measure>
    <time_frame>12 months</time_frame>
    <description>Primary end point is a composite of one or more of :
&gt;50% stenosis of index lesion requiring re-intervention
Re-intervention of index lesion due to clinical indications without 50% re-stenosis
Fistula failure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Technical success</measure>
    <time_frame>Time of baseline index intervention</time_frame>
    <description>Defined as &lt;30% residual stenosis using only the study balloon to which the patient was randomised</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assisted technical success of balloon angioplasty</measure>
    <time_frame>At time of baseline index intervention</time_frame>
    <description>Defined as &lt;30% residual stenosis using adjunctive procedures in addition to study balloon</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Successful use of fistula for dialysis</measure>
    <time_frame>In the 12 months following baseline index intervention</time_frame>
    <description>Defined as successful use of the fistula for dialysis using 2 needles on at least one occasion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Secondary patency of the access circuit</measure>
    <time_frame>In the 12 months following baseline index intervention</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">186</enrollment>
  <condition>Native Arteriovenous Fistula</condition>
  <condition>Stenosis</condition>
  <arm_group>
    <arm_group_label>Experimental</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Drug eluting angioplasty balloons</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Non-drug eluting balloons</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Drug eluting balloons</intervention_name>
    <arm_group_label>Experimental</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Non drug eluting balloons</intervention_name>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Arteriovenous (AV) fistulas with stenosis requiring percutaneous angioplasty
             identified on routine diagnostic imaging or causing clinical concern on dialysis.

          -  Fistula has been in use for at least 1 month and is &gt; 6 weeks old

          -  Brachiocephalic AV fistula

          -  Brachiobasilic AV fistula

          -  Radiocephalic AV fistula (both proximal and distal)

          -  Participant &gt;/=18 yrs old

          -  Index lesion is less then the length of the DEB, and the reference vessel diameter is
             appropriate for treatment with the size range of DEB (4mm - 8mm diameter)

          -  Participant is able to give valid informed consent

        Exclusion Criteria:

          -  Allergy to iodinated Intravenous contrast

          -  Allergy to Paclitaxel

          -  Prosthetic grafts

          -  Long or tandem lesions that cannot be treated with a single DEB

          -  Thrombosed Arterio-Venous fistulas

          -  Women who are breastfeeding, pregnant or intending to become pregnant

          -  Participants of child-bearing age who are unwilling to use a reliable form of
             contraception for the duration of the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert Jones, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospitals Birmingham NHS Foundation Trust</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>N E Anderson</last_name>
    <phone>+441216272000</phone>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospitals Birmingham NHS Foundation Trust</name>
      <address>
        <city>Birmingham</city>
        <state>West Midlands</state>
        <zip>B15 2TH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>R G Jones, Dr</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 21, 2016</study_first_submitted>
  <study_first_submitted_qc>September 9, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 15, 2016</study_first_posted>
  <last_update_submitted>September 9, 2016</last_update_submitted>
  <last_update_submitted_qc>September 9, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 15, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Constriction, Pathologic</mesh_term>
    <mesh_term>Fistula</mesh_term>
    <mesh_term>Arteriovenous Fistula</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

